The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2- metastatic breast cancer administered abemaciclib plus pembrolizumab.
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; Genentech; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Bristol-Myers Squibb; Eisai; Eisai; Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Peter Kabos
Consulting or Advisory Role - Lilly
Research Funding - Radius Health (Inst)
 
Maura N. Dickler
Consulting or Advisory Role - AstraZeneca; Celldex; Genentech/Roche; Hengrui Pharmaceutical ; Lilly; Merrimack; Novartis; Pfizer; Puma Biotechnology; Syndax; TapImmune Inc.
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst)
 
Luca Gianni
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Boehringer Ingelheim; Celgene; Genomic Health; Lilly; Merck Sharp & Dohme; Odonate Therapeutics; Oncolytics; Onkaido Therapeutics; Pfizer; Roche; Sandoz; Sanofi; Seagen; Synaffix; Synthon; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Roche
 
Valerie Jansen
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Yi Lu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Suzanne Young
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Hope S. Rugo
Honoraria - Genomic Health
Consulting or Advisory Role - Amgen
Speakers' Bureau - Genomic Health
Research Funding - Eisai (Inst); Genentech (Inst); GTx (Inst); Immunomedics (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Novartis; OBI Pharma; Pfizer; Puma Biotechnology; Roche/Genentech